WILMINGTON, Del., Sept. 1 /PRNewswire-FirstCall/ -- AstraZeneca
(NYSE: AZN), one of the world's leading pharmaceutical companies, today
announced it will provide a direct cash contribution of $1 million to the
American Red Cross to assist in Hurricane Katrina relief efforts. In addition,
the company will provide free medicines to patients and clinics through the
AstraZeneca Patient Assistance and Caring Partners Programs and to national
and local disaster relief organizations providing aid to the hurricane-
affected areas. The Company will also match dollar-for-dollar all
contributions made by its U.S. employees to the American Red Cross.
"We are dealing with a tragedy beyond anything we could imagine. There are
so many people affected directly and indirectly by this catastrophe.
AstraZeneca is committed, along with the broader healthcare community, to
helping people affected by this terrible event, some of whom include our own
AstraZeneca employees," said David Brennan, President and CEO, AstraZeneca US.
"We are working with the appropriate agencies to coordinate our donations and
will continue to assess the situation to determine how AstraZeneca can help
rebuild the lives and communities devastated by this disaster."
People currently taking AstraZeneca medications who are affected by the
hurricane and currently enrolled in the AstraZeneca Foundation Patient
Assistance Program (PAP) can call 1-800-424-3727 to request a product refill
or replacement, and indicate where they would like it to be shipped in the
event of relocation. These medicines include: ACCOLATE(R) (zafirlukast),
ARIMIDEX(R) (anastrozole), ATACAND(R) (candesartan cilexetil), ATACAND HCT(R)
(candesartan cilexetil-hydrochlorothiazide), CASODEX(R) (bicalutamide),
CRESTOR(R) (rosuvastatin calcium), EMLA Cream (lidocaine 2.5% and prilocaine
2.5%), FASLODEX(R) (fulvestrant), NEXIUM(R) (esomeprazole magnesium),
NOLVADEX(R) (tamoxifen citrate), PLENDIL(R) (felodipine ER), PULMICORT
RESPULES(R) (budesonide inhalation suspension), PULMICORT TURBUHALER(R)
(budesonide inhalation powder), RHINOCORT AQUA(R) (budesonide), SEROQUEL(R)
(quetiapine fumarate), TOPROL-XL(R) (metoprolol succinate), ZOLADEX(R)
(goserelin acetate implant), ZOMIG(R) (zolmitriptan) and ZOMIG ZMT(R)
(zolmitriptan).
Those who previously have been prescribed an AstraZeneca medication but
who are not enrolled in an AstraZeneca Patient Assistance Program are urged to
visit a physician, pharmacist, local clinic/hospital or disaster relief agency
to receive the AstraZeneca product that they have been prescribed. For
further information about clinic locations call the American Red Cross at 1-
800-HELP-NOW.
AstraZeneca is working with the American Red Cross and other agencies to
continually monitor the impact on affected areas and to provide additional
product as needed.
AstraZeneca is a major international healthcare business engaged in the
research, development, manufacture and marketing of prescription
pharmaceuticals and the supply of healthcare services. It is one of the
world's leading pharmaceutical companies with healthcare sales of over $21.4
billion and leading positions in sales of gastrointestinal, cardiovascular,
respiratory, oncology and neuroscience products. In the United States,
AstraZeneca is a $9.6 billion healthcare business with more than 12,000
employees. AstraZeneca is listed in the Dow Jones Sustainability Index
(Global) as well as the FTSE4Good Index.
For more information about AstraZeneca, please visit:
http://www.astrazeneca-us.com
SOURCE AstraZeneca
 back to top
Related links:
http://www.astrazeneca-us.com
Company News On-Call:
http://www.prnewswire.com/comp/985887.html
CONTACT:
Carla Burigatto of AstraZeneca,
+1-302-886-5953, or Carla.Burigatto@astrazeneca.com
|
